US2016046601A1PendingUtilityA1
Heterocyclic compound and use thereof
Est. expiryJun 19, 2028(~1.9 yrs left)· nominal 20-yr term from priority
Inventors:Takanobu KuroitaYasuhiro ImaedaKouichi IwanagaNaohiro TayaHidekazu TokuharaYoshiyuki Fukase
A61P 9/04A61P 9/00A61P 9/12A61P 9/10A61P 43/00A61P 13/12C07D 401/12C07D 417/06C07D 417/12C07D 413/06C07D 487/08C07D 409/06C07D 487/04C07D 405/14C07D 409/14C07D 233/90C07D 453/02C07D 471/04C07D 407/12C07D 413/14C07D 495/04C07D 401/14
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds represented by the formulas wherein each symbol is as defined in the specification, and a prodrug thereof have a superior renin inhibitory activity, and are useful as agents for the prophylaxis or treatment of hypertension, various organ damages attributable to hypertension and the like.
Claims
exact text as granted — not AI-modified1 . A compound represented by the formula (I):
wherein
R 1 is a C 1-6 alkyl group;
R 2 is a group represented by the formula: —CO—NR′R″ wherein R′ and R″ form, to ether with the nitrogen atom bonded thereto, a nitrogen-containing heterocycle;
X is a C 1-6 alkyl group optionally substituted by 1 to 3 substituents selected from the group consisting of
(a) C 1-6 alkoxy group optionally having a C 1-6 alkoxy group, and
(b) an aryloxy group; and
ring A is
(1) triazole optionally further having substituent(s) selected from a C 6-10 aryl group optionally having halogen atom(s),
(2) imidazo[1,2-a]pyridine, or
(3) benzimidazole further having substituent(s) selected from the group consisting of a halogen atom and a C 1-6 alkoxy group,
or a salt thereof.
2 . A compound represented by the formula (II):
wherein
R 1 is a C 1-6 alkyl group;
R 3 is a C 1-6 alkoxy group optionally substituted by a C 1-6 alkoxy group;
X is a C 1-6 alkylene group;
ring A 1 is
(1) triazole optionally further having substituent(s) selected from a C 6-10 aryl group optionally having halogen atom(s),
(2) imidazo[1,2-a]pyridine, or
(3) benzimidazole further having substituent(s) selected from the group consisting of a halogen atom and a C 1-6 alkoxy group; and
the group represented by the formula:
is a group represented by the formula:
wherein R 4 is a group represented by the formula: —CO—NR′R″ wherein R′ and R″ from, together with the nitrogen atom bonded thereto, a nitrogen-containing heterocycle, or a salt thereof.
3 - 4 . (canceled)
5 . The compound of claim 1 , wherein ring A is a ring represented by the formula:
wherein R a and R b are each independently a hydrogen atom, a halogen atom, or a C 1-6 alkoxy group, and at least one of R a and R b is not a hydrogen atom; and
Y 1 is N, and Y 2 is CH.
6 . The compound of claim 2 , wherein ring A 1 is a ring represented by the formula:
wherein R a and R b are each independently a hydrogen atom, a halogen atom, or a C 1-6 alkoxy group, and at least one of R a and R b is not a hydrogen atom; and
Y is N, and Y 2 is CH.
7 . (canceled)
8 . The compound of claim 2 , wherein the group represented by the formula:
is a group represented by the formula:
wherein R 4 is a group represented by the formula: —CO—NR′R″ wherein R′ and R″ form, together with the nitrogen atom bonded thereto, a nitrogen-containing heterocycle.
9 - 20 . (canceled)
21 . 1-(2-Fluorophenyl)-5-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]-1H-1,2,3-triazole-4-carboxamide or a salt thereof.
22 - 31 . (canceled)Join the waitlist — get patent alerts
Track US2016046601A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.